Peter Cordeiro, MD
Plastic and Reconstructive Surgery · New York, NYNPI 1720063712
Payments from drug & device makers
Across 25 payments — averaging $116.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$694
- AbbVie$502
- Vascular Technology, Inc.$400
- Axogen$367
- Sientra, Inc.$339
- Tepha Inc$192
- plus $428 from 5 others
What the payments were for
- Speaking & faculty fees$40014%
- Food & beverage$2,52186%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 6 | $694 |
| AbbVie(2 entities) | 8 | $502 |
| Vascular Technology, Inc. | 1 | $400 |
| Axogen | 2 | $367 |
| Sientra, Inc. | 2 | $339 |
| Tepha Inc | 1 | $192 |
| RTI Surgical, Inc | 1 | $155 |
| KCI USA, Inc. | 1 | $94 |
| Mentor Worldwide LLC | 1 | $78 |
| Polynovo North America LLC | 1 | $52 |
| Davol Inc. | 1 | $49 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,921 in reported general payments places this provider in the 65th percentile of 219 plastic and reconstructive surgery providers in New York.
See all plastic and reconstructive surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in New York
- Babak MehraraNew York$756K
- Lawrence BassNew York$341K
- Robert GrantNew York$207K
- Christine RohdeNew York$180K
- Graham SchwarzNew York$125K
- Steven LevineNew York$108K
- Mark AlbertNew York$105K
- Theodore DiktabanNew York$83K
- Nicholas BastidasNew York$27K
- Philip MillerNew York$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.